1
|
Ruiz-Molina YG, Herrera-Ávila J, Espinosa-Juárez JV, Esquinca-Avilés HA, Tejas-Juárez JG, Flores-Guillén E, Morales-Martínez LA, Briones-Aranda A, Jiménez-Ceballos B, Sierra-Ramírez JA, Cruz-Trujillo R. Association of Overweight and Obesity with Impaired Executive Functioning in Mexican Adolescents: The Importance of Inhibitory Control. Healthcare (Basel) 2024; 12:1368. [PMID: 39057511 PMCID: PMC11275439 DOI: 10.3390/healthcare12141368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Revised: 06/13/2024] [Accepted: 07/04/2024] [Indexed: 07/28/2024] Open
Abstract
Overweight and obesity are major public health issues worldwide, including in Mexico, particularly among adolescents. This study aimed to analyze the associations between nutritional status and impaired executive function (EF) in Mexican adolescents. A case-control study was conducted with 98 male and female adolescents, categorized into normal weight and overweight/obese groups based on body mass index. EF was assessed using the BANFE-2 test. The prevalence of overweight and obesity was 54.3%. The EF assessment revealed that 82.45% of the overweight/obese group exhibited mild-to-severe impairment, compared to only 36.58% in the normal weight group (X2 = 21.69, p < 0.0001). In the inhibitory control assessment, adolescents with overweight and obesity performed worse than their normal-weight counterparts. Specifically, females with overweight/obesity scored lower than females with normal weight on the risk-benefit processing test. The risk of severe EF impairment significantly increased with the presence of overweight/obesity (OR = 7.8, p < 0.0001). These findings indicate that EF, particularly inhibitory control and risk-benefit processing, is impaired in adolescents with overweight or obesity.
Collapse
Affiliation(s)
- Yatzeny Guadalupe Ruiz-Molina
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico; (Y.G.R.-M.); (J.H.-Á.)
| | - Josué Herrera-Ávila
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico; (Y.G.R.-M.); (J.H.-Á.)
| | - Josué Vidal Espinosa-Juárez
- Escuela de Ciencias Químicas, Universidad Autónoma de Chiapas (UNACH), Carretera Panamericana Ocozocoautla-Cintalapa Km. 2.5, Ocozocoautla de Espinosa 29140, Mexico; (J.V.E.-J.); (H.A.E.-A.)
| | - Héctor Armando Esquinca-Avilés
- Escuela de Ciencias Químicas, Universidad Autónoma de Chiapas (UNACH), Carretera Panamericana Ocozocoautla-Cintalapa Km. 2.5, Ocozocoautla de Espinosa 29140, Mexico; (J.V.E.-J.); (H.A.E.-A.)
| | - Juan Gabriel Tejas-Juárez
- División Académica Multidisciplinaria de Comalcalco, Universidad Juárez Autónoma de Tabasco, Tabasco 86658, Mexico;
| | - Elena Flores-Guillén
- Facultad de Ciencias de la Nutrición y Alimentos, Universidad de Ciencias y Artes de Chiapas (UNICACH), Libramiento Norte-Poniente 1150, Col. Lajas Maciel, Tuxtla Gutiérrez 29039, Mexico; (E.F.-G.); (L.A.M.-M.)
| | - Luis Alberto Morales-Martínez
- Facultad de Ciencias de la Nutrición y Alimentos, Universidad de Ciencias y Artes de Chiapas (UNICACH), Libramiento Norte-Poniente 1150, Col. Lajas Maciel, Tuxtla Gutiérrez 29039, Mexico; (E.F.-G.); (L.A.M.-M.)
| | - Alfredo Briones-Aranda
- Facultad de Medicina Humana Campus II, Universidad Autónoma de Chiapas (UNACH), Décima Sur esquina Calle Central S/N, Tuxtla Gutiérrez 29050, Mexico;
| | - Betsabé Jiménez-Ceballos
- Clínica de Trastornos del Sueño, Universidad Autónoma Metropolitana, Unidad Iztapalapa (UAM-I), Av. San Rafael Atlixco 185, Col. Leyes de Reforma, Iztapalapa, Ciudad de Mexico 09340, Mexico;
| | - José Alfredo Sierra-Ramírez
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico; (Y.G.R.-M.); (J.H.-Á.)
| | - Refugio Cruz-Trujillo
- Escuela de Ciencias Químicas, Universidad Autónoma de Chiapas (UNACH), Carretera Panamericana Ocozocoautla-Cintalapa Km. 2.5, Ocozocoautla de Espinosa 29140, Mexico; (J.V.E.-J.); (H.A.E.-A.)
- Departamento de Químicos Farmacobiólogos, Universidad Pablo Guardado Chávez (UPGCH), Libramiento Norte Oriente No. 3450, Tuxtla Gutiérrez 29040, Mexico
| |
Collapse
|
2
|
Hansen B, Roomp K, Ebid H, Schneider JG. Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans. Adv Nutr 2024; 15:100197. [PMID: 38432589 PMCID: PMC10997874 DOI: 10.1016/j.advnut.2024.100197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Revised: 11/29/2023] [Accepted: 02/23/2024] [Indexed: 03/05/2024] Open
Abstract
Neurodegenerative diseases (NDs) are characterized by the progressive functional and structural denaturation of neurons in the central and peripheral nervous systems. Despite the wide range of genetic predispositions, the increased emergence of these disorders has been associated with a variety of modifiable risk factors, including lifestyle factors. Diet has been shown to influence cognitive alterations in the elderly population with age-related brain pathologies, and specific dietary interventions might, therefore, confer preservatory protection to neural structures. Although Mediterranean and ketogenic diets have been studied, no clear guidelines have been implemented for the prevention or treatment of ND in clinical practice. Murine models have shown that intermittent fasting and caloric restriction (CR) can counteract disease processes in various age-related disorders, including NDs. The objective of this perspective is to provide a comprehensive, comparative overview of the available primary intervention studies on fasting and CR in humans with ND and to elucidate possible links between the mechanisms underlying the effects of fasting, CR, and the neuropathology of ND. We also included all currently available studies in older adults (with and without mild cognitive impairment) in which the primary endpoint was cognitive function to provide further insights into the feasibility and outcomes of such interventions. Overall, we conclude that nutritional intervention trials focusing on fasting and CR in humans with ND have been neglected, and more high-quality studies, including longitudinal clinical intervention trials, are urgently needed to elucidate the underlying immune-metabolic mechanisms in diet and ND.
Collapse
Affiliation(s)
- Bérénice Hansen
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
| | - Kirsten Roomp
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
| | - Hebah Ebid
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
| | - Jochen G Schneider
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Departments of Internal Medicine II and Psychiatry, Saarland University Medical Center, Homburg, Germany.
| |
Collapse
|
3
|
de Vargas LDS, Jantsch J, Fontoura JR, Dorneles GP, Peres A, Guedes RP. Effects of Zinc Supplementation on Inflammatory and Cognitive Parameters in Middle-Aged Women with Overweight or Obesity. Nutrients 2023; 15:4396. [PMID: 37892471 PMCID: PMC10609714 DOI: 10.3390/nu15204396] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Revised: 10/03/2023] [Accepted: 10/11/2023] [Indexed: 10/29/2023] Open
Abstract
Obesity has been linked to cognitive decline and adverse effects on brain health. Zinc (Zn) is a mineral with important metabolic functions that can modulate obesity-related neurological impairment. Thus, the present study aimed to evaluate the effects of 12 weeks of Zn supplementation on the inflammatory profile, cognitive function, and mood of overweight or obese women through a double-blind, placebo-controlled study. The study included 42 women aged between 40 and 60, randomly divided into two groups: Zn supplementation (30 mg/day) or placebo for 12 weeks. Data regarding sociodemographic, anthropometric, dietary, and physical activity were collected. Mini-mental state examination (MMSE), verbal fluency test, clock drawing test, and Stroop test were performed. Anxiety and depression symptoms were assessed using the Beck anxiety inventory and the BDI-II, respectively. Saliva samples were collected to evaluate IL-1β, IL-6, TNF-α, insulin, nitrite, and Zn levels. Of the 42 participants (mean age 49.58 ± 6.46 years), 32 were included in the study analyses. Changes in body weight and macronutrient consumption were not different between placebo and Zn supplementation groups. Cognitive scores on the MMSE and Stroop tests were higher in the Zn supplementation group than in the placebo group. Salivary levels of IL-1b and Zn increased in the Zn group compared to placebo. There was no significant change in the adjusted means of the BDI-II and BECK scores between the zinc vs. placebo groups. Twelve weeks of Zn supplementation was able to partially improve the cognitive scores assessed in overweight or obese women, regardless of weight loss. These findings suggest that Zn supplementation can be considered an adjunct strategy to enhance cognitive health in overweight or obese women.
Collapse
Affiliation(s)
- Liziane da Silva de Vargas
- Programa de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil; (L.d.S.d.V.); (J.J.); (A.P.)
| | - Jeferson Jantsch
- Programa de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil; (L.d.S.d.V.); (J.J.); (A.P.)
| | - Juliana Ribeiro Fontoura
- Graduação em Nutrição, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil
| | - Gilson Pires Dorneles
- Hospital Moinhos de Vento, Rua Ramiro Barcelos, 910, Porto Alegre 90035-000, Brazil;
| | - Alessandra Peres
- Programa de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil; (L.d.S.d.V.); (J.J.); (A.P.)
- Graduação em Nutrição, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil
- Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil
| | - Renata Padilha Guedes
- Programa de Pós-Graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil; (L.d.S.d.V.); (J.J.); (A.P.)
- Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, Porto Alegre 90050-170, Brazil
| |
Collapse
|
4
|
Mancilla-Corona CO, Sanchez-Alavez M, Pineda-García G, Islas-Limon JY, Zazueta OE, Lopez-Baena JV, Rodríguez-Vásquez JI, Serafin-Higuera IR. The influence of physical fatigue on telephone-based neuropsychological test performance in COVID-19 survivors. Eur Arch Psychiatry Clin Neurosci 2023:10.1007/s00406-023-01638-2. [PMID: 37336825 DOI: 10.1007/s00406-023-01638-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Accepted: 06/03/2023] [Indexed: 06/21/2023]
Abstract
Fatigue has been characterized as a post COVID-19 condition known to persist months after SARS-CoV-2 infection. COVID-19 has been reported to be associated with impaired cognitive function, including disorders in attention, memory, information processing, and executive functions. The objective of this study was to determine if post-COVID fatigue, manifested as tiredness while performing low-intensity physical activity, has a detrimental effect on neuropsychological performance, to achieve this, we randomly selected 20 participants with post-COVID fatigue and 20 SARS-CoV-2 negative age-matched controls from a database of 360 residents of Tijuana, Baja California in a cross-sectional study design. All 40 participants responded to a health survey, along with a neuropsychological assessment test via telephone call. Statistical analysis was performed using a multiple linear regression model including the following independent variables: study condition (post-COVID fatigue or negative control), sex, age, years of education, hypertension, asthma, administration of supplemental oxygen during COVID-19 recovery, and the hour at which the evaluation started. Significant regression analysis was obtained for all global parameters of the assessment, including BANFE-2 score (p = 0.021, R2 Adj. = 0.263), NEUROPSI score (p = 0.008, R2 Adj. = 0.319), and total errors (p = 0.021, R2 Adj. = 0.263), with significant regression coefficients for study condition on two global parameters, BANFE-2 score (p = 0.028, β = - 0.371) and NEUROPSI score (p = 0.010, β = -0.428). These findings suggest that the presence of post-COVID fatigue is a factor associated with a decrease in neuropsychological performance.
Collapse
Affiliation(s)
- Cristian O Mancilla-Corona
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico.
| | - Manuel Sanchez-Alavez
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico
- Molecular Medicine, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA
| | - Gisela Pineda-García
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico
| | - Julieta Y Islas-Limon
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico
| | - Oscar E Zazueta
- Baja California Ministry of Health, Pioneros No. 1005 Centro, 21000, Mexicali, BC, Mexico
| | - Jonathan V Lopez-Baena
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico
| | - Jesús I Rodríguez-Vásquez
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico
| | - Idanya R Serafin-Higuera
- Centro de Diagnóstico COVID-19, Facultad de Medicina y Psicología, Calzada Tecnológico y Universidad S/N Delegación Mesa de Otay, 22390, Tijuana, BC, Mexico.
| |
Collapse
|